XML 27 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 02, 2022
Jan. 03, 2021
Dec. 29, 2019
Income Statement [Abstract]      
Revenue [1] $ 783,279 $ 844,836 $ 1,198,301
Cost of revenue [1] 812,293 854,617 1,200,610
Gross loss (29,014) (9,781) (2,309)
Operating expenses      
Research and development expense [1] 46,527 34,194 36,997
Sales, general and administrative [1] 88,822 86,202 96,857
Restructuring charges (credits) 8,084 0 (517)
Total operating expenses 143,433 120,396 133,337
Operating loss (172,447) (130,177) (135,646)
Other (expense) income, net      
Interest expense [1] (27,848) (31,859) (25,831)
Loss on extinguishment of debt (5,075) 0 0
Other, net (33,693) 36,349 (1,961)
Other (expense) income, net (66,616) 4,490 (27,792)
Loss before income taxes and equity in losses of unconsolidated investees (239,063) (125,687) (163,438)
Provision for income taxes (203) (12,127) (10,122)
Equity in losses of unconsolidated investees (16,480) (3,198) (5,342)
Net loss (255,746) (141,012) (178,902)
Net loss (income) attributable to noncontrolling interests 1,226 (1,619) (4,157)
Net loss attributable to stockholders $ (254,520) $ (142,631) $ (183,059)
Loss per share:      
Basic (USD per share) $ (6.79) $ (5.82) $ (8.61)
Diluted (USD per share) $ (6.79) $ (5.82) $ (8.61)
Weighted average shares used in loss per share computation:      
Basic (shares) 37,457 24,502 21,265
Diluted (shares) 37,457 24,502 21,265
[1] We have related-party transactions with Tianjin Zhonghuan Semiconductor Co., Ltd, SunPower and TotalEnergies S.E. and its affiliates as well as unconsolidated entities in which we have a direct equity investment. These related-party transactions are recorded within the “Revenue,” “Cost of revenue,” “Operating expenses: Research and development and Sales, general and administrative,” and “Other expense, net: Interest expense” financial statement line items in our Consolidated and Combined Statements of Operations (see Note 3, Note 4 and Note 10).